The Pathology Services industry provides vital information that helps doctors to diagnose and manage a number of diseases. The ageing population and an increase in the prevalence of chronic illness are factors promoting demand for health services and referrals for pathology services. The industry derives the vast majority of its revenue from providing pathology services under Medicare.
The industry is expected to grow by 2.9% in 2014-15, to reach $2.8 billion. Medicare is expected to record more than 118.0 million pathology services in 2014-15, up from 93.0 million services in 2009-10, suggesting strong volume growth over the past five years.
Companies in this industry operate pathology laboratories and collection centres. Pathology services provided by public laboratories operating within general hospitals are excluded.
The report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecast, growth rates and an analysis of the industry key players and their market shares.